Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 1
Submit an article Journal homepage
383
Views
26
CrossRef citations to date
0
Altmetric
Letter to the Editor

Plasmablastic lymphoma among human immunodeficiency virus-positive patients: results of a single center's experience

Chiara CattaneoDepartment of Hematology, Spedali Civili, Brescia, ItalyCorrespondence[email protected]
,
Alessandro ReDepartment of Hematology, Spedali Civili, Brescia, Italy
,
Marco UngariDepartment of Pathology, University of Brescia, Spedali Civili, Brescia, Italy
,
Annalisa PeliDepartment of Hematology, Spedali Civili, Brescia, Italy
,
Salvatore CasariII Department of Infectious Disease, University of Brescia, Spedali Civili, Brescia, Italy
,
Filippo CastelnuovoI Department of Infectious Disease, Spedali Civili, Brescia, Italy
,
Simona FisogniDepartment of Pathology, University of Brescia, Spedali Civili, Brescia, Italy
,
Silvia LonardiDepartment of Pathology, University of Brescia, Spedali Civili, Brescia, Italy
,
Vilma PellegriniDepartment of Pathology, University of Brescia, Spedali Civili, Brescia, Italy
,
Marta PetullàDepartment of Hematology, Spedali Civili, Brescia, Italy
,
Fabio FacchettiDepartment of Pathology, University of Brescia, Spedali Civili, Brescia, Italy
&
Giuseppe RossiDepartment of Hematology, Spedali Civili, Brescia, Italy
 show all
Pages 267-269 | Received 17 Dec 2013, Accepted 31 Mar 2014, Published online: 16 Jun 2014

References

  • Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997;89:1413–1420.
  • Sarode SC, Sarode GS, Patil A. Plasmablastic lymphoma of the oral cavity: a review. Oral Oncol 2010;46:146–153.
  • Cattaneo C, Facchetti F, Re A, et al. Oral cavity lymphomas in immunocompetent and human immunodeficiency virus infected patients. Leuk Lymphoma 2005;46:77–81.
  • Teruya-Feldstein J, Chiao E, Filippa DA, et al. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 2004;15:1673–1679.
  • Carbone A, Gloghini A, Larocca LM, et al. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood 2001;97:744–751.
  • Carbone A, Ceserman E, Spina M, et al. HIV-associated lymphomas and gamma-herpesviruses. Blood 2009;113:1213–1224.
  • Bogusz AM, Seegmiller AC, Garcia R, et al. Plasmablastic lymphomas with MYC/IgH rearrangement: report of three cases and review of the literature. Am J Clin Pathol 2009;132:597–605.
  • Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol 2008;83:804–809.
  • Castillo JJ, Reagan JL. Plasmablastic lymphoma: a systematic review. Sci World J 2011;11:687–696.
  • Castillo JJ, Furman M, Beltrán BE, et al. Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy. Cancer 2012;118:5270–5277.
  • Schommers P, Wyen C, Hentrich M, et al. Poor outcome of HIV-infected patients with plasmablastic lymphoma: results from the German AIDS-related lymphoma cohort study. AIDS 2013; 27:842–845.
  • Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25:579–586.
  • Antinori A, Cingolani A, Alba L, et al. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS 2001;15:1483–1491.
  • Re A, Tucci A, Casari S, et al. Treating lymphoma with curative intent in HIV positive patients after the advent of HAART: a comparative analysis with the HIV negative population. Blood 2008;112(Suppl. 1): Abstract 3603.
  • Bibas M, Grisetti S, Alba L, et al. Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone. J Clin Oncol 2010;28:e704–e708.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.